Aken Desai1, John C Messenger2, Robert Quaife2, John Carroll2. 1. Division of Cardiovascular Medicine, Department of Medicine, University of Colorado Anschutz School of Medicine, 12401 E. 17th Ave, Leprino Building, Room 511, Mail Stop B132, Aurora, CO, 80045, USA. aken.desai@cuanschutz.edu. 2. Division of Cardiovascular Medicine, Department of Medicine, University of Colorado Anschutz School of Medicine, 12401 E. 17th Ave, Leprino Building, Room 511, Mail Stop B132, Aurora, CO, 80045, USA.
Abstract
PURPOSE OF REVIEW: Given the low occurrence of clinically important paravalvular leak (PVL), there are no large registries or trials in this space to investigate management strategies. This review integrates newer evidence, particularly in imaging guidance for these complex procedures, novel techniques and approaches that our group has taken, as well as approaches to more complex PVL plugging reported in case reports. RECENT FINDINGS: Perhaps the largest area of growth in the management of PVL is the use of advanced imaging in both pre-procedure evaluation and intra-procedural guidance with gated cardiac CT, 3D TEE, and fluoroscopy fusion technologies. Outside the USA, a new device, the Occlutech PLD, has become available with early data indicating high success rates. There remains little randomized data to support the efficacy of percutaneous PVL closure. Gated cardiac CT has become key to the pre-procedure evaluation for transcatheter closure as it allows for increased procedural efficiency and more accurate pre-procedure planning, particularly when combined with 3D printing. Intra-procedural TEE-fluoro fusion allows for more rapid crossing of defects by providing a visual target for interventionalists. The advent of purpose-built devices for PVL closure may further increase the efficacy and efficiency of percutaneous closure, but significant barriers remain for approval of these devices in the USA.
PURPOSE OF REVIEW: Given the low occurrence of clinically important paravalvular leak (PVL), there are no large registries or trials in this space to investigate management strategies. This review integrates newer evidence, particularly in imaging guidance for these complex procedures, novel techniques and approaches that our group has taken, as well as approaches to more complex PVL plugging reported in case reports. RECENT FINDINGS: Perhaps the largest area of growth in the management of PVL is the use of advanced imaging in both pre-procedure evaluation and intra-procedural guidance with gated cardiac CT, 3D TEE, and fluoroscopy fusion technologies. Outside the USA, a new device, the Occlutech PLD, has become available with early data indicating high success rates. There remains little randomized data to support the efficacy of percutaneous PVL closure. Gated cardiac CT has become key to the pre-procedure evaluation for transcatheter closure as it allows for increased procedural efficiency and more accurate pre-procedure planning, particularly when combined with 3D printing. Intra-procedural TEE-fluoro fusion allows for more rapid crossing of defects by providing a visual target for interventionalists. The advent of purpose-built devices for PVL closure may further increase the efficacy and efficiency of percutaneous closure, but significant barriers remain for approval of these devices in the USA.
Authors: K Hammermeister; G K Sethi; W G Henderson; F L Grover; C Oprian; S H Rahimtoola Journal: J Am Coll Cardiol Date: 2000-10 Impact factor: 24.094
Authors: Martin B Leon; Craig R Smith; Michael Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; David L Brown; Peter C Block; Robert A Guyton; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Pamela S Douglas; John L Petersen; Jodi J Akin; William N Anderson; Duolao Wang; Stuart Pocock Journal: N Engl J Med Date: 2010-09-22 Impact factor: 91.245
Authors: Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock Journal: N Engl J Med Date: 2011-06-05 Impact factor: 91.245
Authors: Carlos E Ruiz; Rebecca T Hahn; Alain Berrebi; Jeffrey S Borer; Donald E Cutlip; Greg Fontana; Gino Gerosa; Reda Ibrahim; Vladimir Jelnin; Hasan Jilaihawi; E Marc Jolicoeur; Chad Kliger; Itzhak Kronzon; Jonathon Leipsic; Francesco Maisano; Xavier Millan; Patrick Nataf; Patrick T O'Gara; Philippe Pibarot; Stephen R Ramee; Charanjit S Rihal; Josep Rodes-Cabau; Paul Sorajja; Rakesh Suri; Julie A Swain; Zoltan G Turi; E Murat Tuzcu; Neil J Weissman; Jose L Zamorano; Patrick W Serruys; Martin B Leon Journal: J Am Coll Cardiol Date: 2017-04-25 Impact factor: 24.094
Authors: Michael E Bowdish; Richard S D'Agostino; Vinod H Thourani; Nimesh Desai; David M Shahian; Felix G Fernandez; Vinay Badhwar Journal: Ann Thorac Surg Date: 2020-04-02 Impact factor: 4.330
Authors: Lars Englberger; Hartzell V Schaff; W R Eric Jamieson; Elizabeth D Kennard; Kyung A Im; Richard Holubkov; Thierry P Carrel Journal: Eur J Cardiothorac Surg Date: 2005-11-07 Impact factor: 4.191
Authors: Vuyisile T Nkomo; Julius M Gardin; Thomas N Skelton; John S Gottdiener; Christopher G Scott; Maurice Enriquez-Sarano Journal: Lancet Date: 2006-09-16 Impact factor: 79.321
Authors: John D Carroll; Michael J Mack; Sreekanth Vemulapalli; Howard C Herrmann; Thomas G Gleason; George Hanzel; G Michael Deeb; Vinod H Thourani; David J Cohen; Nimesh Desai; Ajay J Kirtane; Susan Fitzgerald; Joan Michaels; Carole Krohn; Frederick A Masoudi; Ralph G Brindis; Joseph E Bavaria Journal: J Am Coll Cardiol Date: 2020-11-24 Impact factor: 24.094
Authors: Vishal N Shah; Oleg I Orlov; Cinthia P Orlov; Meghan Buckley; Serge Sicouri; Manabu Takebe; Matthew P Thomas; Scott M Goldman; Konstadinos A Plestis Journal: Innovations (Phila) Date: 2019-09-09